IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment. (May 2021)
- Record Type:
- Journal Article
- Title:
- IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment. (May 2021)
- Main Title:
- IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment
- Authors:
- Zhang, Shaopeng
Gan, Xiaojie
Qiu, Jiannan
Ju, Zheng
Gao, Ji
Zhou, Jinren
Shi, Chengyu
Zhu, Yaqing
Li, Zhang - Abstract:
- Highlights: Hepatocarcinoma cells (HCC) derived supernatants inducing decreased apoptosis and greater stability of Foxp3 in human iTreg cells. Pro-inflammatory cytokines in iTregs are inhibited by HepG2 Supernatants. Supernatants derived from HCC also reverse IL-1β/6 triggered decline on Foxp3 in iTregs. Improved stability and function of HepG2 supernatants treated iTregs is IL-10—JAK1—STAT5 signal pathway-dependent. Abstract: Forkhead box P3 (Foxp3) expressing CD4 + CD25 + regulatory T cells (Tregs), an essential subset of immune T cells for maintaining immune homeostasis is implicated as a negative regulator in an anti-tumor immune response. Current researches suggest that reducing tumor-infiltrating Tregs contribute to enhanced anti-cancer effect. However, the mechanism of infiltration of a large number of Tregs into tumor tissues is still unclear. In this study, human induced Tregs (iTregs) were co-cultured with human hepatocytes and various types of cancer cells (HepG2, NSCLC, and AsPC-1) supernatants. Foxp3, multiple cytokines, levels of apoptosis and suppressive ability of iTregs were detected by FACS. Western blot was employed to test of proteins. Impact of HepG2 supernatants on T cell subpopulations differentiation, cytokines in supernatants were examed by FACS and ELISA respectively. Anti-IL-10R antibody and JAK1 inhibitor were used to reconfirm the role of tumor-derived IL-10 play in the regulation on iTregs. Hepatocarcinoma cells (HCC) supernatants treatmentHighlights: Hepatocarcinoma cells (HCC) derived supernatants inducing decreased apoptosis and greater stability of Foxp3 in human iTreg cells. Pro-inflammatory cytokines in iTregs are inhibited by HepG2 Supernatants. Supernatants derived from HCC also reverse IL-1β/6 triggered decline on Foxp3 in iTregs. Improved stability and function of HepG2 supernatants treated iTregs is IL-10—JAK1—STAT5 signal pathway-dependent. Abstract: Forkhead box P3 (Foxp3) expressing CD4 + CD25 + regulatory T cells (Tregs), an essential subset of immune T cells for maintaining immune homeostasis is implicated as a negative regulator in an anti-tumor immune response. Current researches suggest that reducing tumor-infiltrating Tregs contribute to enhanced anti-cancer effect. However, the mechanism of infiltration of a large number of Tregs into tumor tissues is still unclear. In this study, human induced Tregs (iTregs) were co-cultured with human hepatocytes and various types of cancer cells (HepG2, NSCLC, and AsPC-1) supernatants. Foxp3, multiple cytokines, levels of apoptosis and suppressive ability of iTregs were detected by FACS. Western blot was employed to test of proteins. Impact of HepG2 supernatants on T cell subpopulations differentiation, cytokines in supernatants were examed by FACS and ELISA respectively. Anti-IL-10R antibody and JAK1 inhibitor were used to reconfirm the role of tumor-derived IL-10 play in the regulation on iTregs. Hepatocarcinoma cells (HCC) supernatants treatment increases Foxp3 stability and reduces apoptosis level in human iTregs without influencing its differentiation trend. Furthermore, IL-10 was found to be extremely higher in HCC supernatants than other groups, IL-10R blockade neutralize the effect of HCC supernatants on iTregs in vitro obviously. HCC supernatants also reversed IL-1β/6 triggered decline on Foxp3 which may be related to higher expression of JAK1 and elevated phosphorylation level of STAT5 induced by IL-10. Our results suggest that improved stability and abnormal accumulation of Tregs in tumor microenvironment is IL-10/JAK1/STAT5 signal pathway-dependent and provide a novel approach for improving the efficiency of anti-tumor immunotherapy. … (more)
- Is Part Of:
- Molecular immunology. Volume 133(2021)
- Journal:
- Molecular immunology
- Issue:
- Volume 133(2021)
- Issue Display:
- Volume 133, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 133
- Issue:
- 2021
- Issue Sort Value:
- 2021-0133-2021-0000
- Page Start:
- 163
- Page End:
- 172
- Publication Date:
- 2021-05
- Subjects:
- iTregs -- IL-10 -- HCC -- Foxp3 -- STAT5
Immunochemistry -- Periodicals
Molecular biology -- Periodicals
Immunochemistry -- Periodicals
Allergy and Immunology -- Periodicals
Molecular Biology -- Periodicals
Immunochimie -- Périodiques
Biologie moléculaire -- Périodiques
Immunochemistry
Molecular biology
Periodicals
Electronic journals
571.96 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01615890 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.molimm.2021.02.014 ↗
- Languages:
- English
- ISSNs:
- 0161-5890
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16114.xml